Institute Of Liver & Biliary Sciences
An Autonomous Institute
under Government of NCT of Delhi
 
 
SPEAKERS IN SYMPOSIUM

Dr. Riad Salem MD, MBA
Professor of Radiology, Medicine and Surgery
Director, Interventional Oncology
Division of Interventional Radiology
Department of Radiology
Northwestern University
676 N St Clair, Suite 800
Chicago, IL 60611

Dr. Vijay Kumar
Staff Research Scientist
Virology Group
International Center for Genetic
Engineering & Biotechnology (ICGEB)
Aruna Asaf Ali Marg
New Delhi-110067, INDIA


Dr. Samir Shah is a
Consultant Hepatologist
attached to Jaslok
Hospital and Research
Centre. After finishing
M.D. in medicine from
Grant Medical College,
Bombay in 1982,
he was the selected
to do a two-years
degree course in
Gastroenterology at
the Christian Medical
College, Vellore.
He has been a
member of the
Editorial Board of
Indian Journal of
Gastroenterology and
was elected as the
Secretary of the
Indian Association for
study of the liver
for the period
1995-1997.

Dr. AJAI KHANNA
Professor of Surgery
University of California, San
Diego Director Pediatric
Abdominal Transplant Programs
Rady Children’s Hospital
of San Diego

Prof. Mohandas K. Mallath, M.D.
Dean-Academic Tata Memorial
Centre Head, Department of
Digestive Diseases and
Clinical Nutrition
Room 24, Main Building
Tata Memorial Hospital
Mumbai 400012, India

Henry Masur, M.D.
Chief Critical Care Medicine
Department Warren Magnuson
ClinicalCenter National Institutes
of Health Bethesda, Maryland

Atul, Patel K.
Chief consultant; Infectious
Diseases clinic Infectious
Diseases Clinic, 3rd Floor,
“VEDANTA” Institute of Medical
Sciences. Navarangpura.
Ahmedabad. 380 009
 
Chronic hepatitis B and C represent a leading cause of morbidity and mortality among human immunodeficiency virus(HIV)-infectedpatients worldwide. Primary hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide. The goal of the two-day event is to address knoweldge gaps in the areas surrounding

Hepatocellular carcinoma (HCC) is a complex and heterogeneous tumor with the several genomic alterations. Biomarkers and molecular imaging are coming to forefront gradually. The conference will include several presentations on HCC covering various aspects including preparation......